BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29766707)

  • 1. Squamous cell carcinoma developed after ingenol mebutate therapy: a possible consequence of the treatment?
    Maglie R; Grandi V; Maio V; Pileri A
    G Ital Dermatol Venereol; 2018 Jun; 153(3):442-443. PubMed ID: 29766707
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rapidly growing squamous cell carcinoma after ingenol mebutate treatment].
    Ehret M; Velter C; Tebacher M; Bruant-Rodier C; Cribier B
    Ann Dermatol Venereol; 2018 Oct; 145(10):607-612. PubMed ID: 29779859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PICATO (ingenol mebutate 0.015% and 0.05% gels): a novel treatment for actinic keratosis.
    Abramovits W; Oquendo M; Vincent KD; Gupta AK
    Skinmed; 2013; 11(2):111-5. PubMed ID: 23745230
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer.
    Erlendsson AM
    Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiple cutaneous squamous cell carcinoma after treatment with ingenol mebutate].
    Chabbert C; Levy M; Legrand L
    Ann Dermatol Venereol; 2019 Dec; 146(12):823-825. PubMed ID: 31526534
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapidly-growing squamous cell carcinoma shortly after treatment with ingenol mebutate for actinic keratoses: report of two cases.
    Moreno Romero JA; Campoy A; Perez N; Garcia F; Grimalt R
    Br J Dermatol; 2015 Dec; 173(6):1514-7. PubMed ID: 26227007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis.
    Berman B
    Expert Opin Drug Saf; 2015; 14(12):1969-78. PubMed ID: 26524598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erosive pustular dermatosis of the scalp following topical ingenol mebutate for actinic keratoses.
    Vaccaro M; Borgia F; Gasco L; Cannavò SP
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28685901
    [No Abstract]   [Full Text] [Related]  

  • 9. Ingenol Mebutate and the Treatment of Actinic Keratosis.
    Heron CE; Feldman SR
    J Drugs Dermatol; 2021 Jan; 20(1):102-104. PubMed ID: 33400406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ingenol mebutate: a new option for actinic keratosis treatment.
    Gras J
    Drugs Today (Barc); 2013 Jan; 49(1):15-22. PubMed ID: 23362492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Histologic Evaluation of Ingenol Mebutate 0.015% Gel for the Cosmetic Improvement of Photoaged Skin.
    Handler MZ; Bloom BS; Goldberg DJ
    Dermatol Surg; 2018 Jan; 44(1):61-67. PubMed ID: 28858927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erosive pustular dermatosis of the scalp induced by ingenol mebutate.
    Brambilla L; Tourlaki A; Nazzaro G
    G Ital Dermatol Venereol; 2018 Oct; 153(5):743-745. PubMed ID: 28895376
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of Efficacy and Irritation of Ingenol Mebutate Gel 0.015% Used With or Without Dimethicone Lotion for Treatment of Actinic Keratosis on the Face.
    Jim On SC; Hashim PW; Nia JK; Lebwohl MG
    J Drugs Dermatol; 2017 May; 16(5):432-436. PubMed ID: 28628678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ingenol Mebutate 500 µg on the Cheekbones with Concomitant Conjunctivitis.
    Gaide O; Cattin V
    Dermatology; 2016; 232 Suppl 1():4-6. PubMed ID: 27513756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.
    Bettencourt MS
    J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Field Treatment of Actinic Keratosis With Ingenol Mebutate Gel on the Identification of Lesions for Biopsy.
    Bettencourt MS
    J Drugs Dermatol; 2015 Aug; 14(8):813-8. PubMed ID: 26267725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bullous reaction after application of a single dose ingenol mebutate].
    Salskov-Iversen ML; Lorentzen HF
    Ugeskr Laeger; 2013 Dec; 175(49A):V07130437. PubMed ID: 25353257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis.
    Stockfleth E; Bastian M
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):911-918. PubMed ID: 30074409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
    N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses.
    Lebwohl M; Shumack S; Stein Gold L; Melgaard A; Larsson T; Tyring SK
    JAMA Dermatol; 2013 Jun; 149(6):666-70. PubMed ID: 23553119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.